Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.130
+0.170 (5.74%)
At close: Feb 18, 2026, 4:00 PM EST
3.100
-0.030 (-0.96%)
After-hours: Feb 18, 2026, 7:46 PM EST
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $301.31 million as of February 18, 2026. Its market cap has increased by 157.93% in one year.
Market Cap
301.31M
Enterprise Value
167.16M
1-Year Change
157.93%
Ranking
Category
Stock Price
$3.13
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $301.31M, an increase of 27.93%. That is a compound annual growth rate of 3.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 284.95M | 35.16% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 276.61M |
| Relmada Therapeutics | 272.80M |
| Abeona Therapeutics | 271.50M |
| Minerva Neurosciences | 271.33M |
| Climb Bio | 270.71M |
| Larimar Therapeutics | 269.61M |
| Neurogene | 269.21M |
| Sutro Biopharma | 264.83M |